GOG3041 Durvalumab w wo Olaparib as Maint Therapy After 1stLine Trt of Adv Recur EC
Full Title:
A Randomised Multicentre Doubleblind Placebocontrolled Phase III Study of Firstline Carboplatin and Paclitaxel in Combination with Durvalumab Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer DUOE
Status:
OPEN TO ACCRUAL
Protocol Number:
2101341520
Principal Investigator:
Phase:
III
Prevention or Control:
Age Group:
Scope:
Disease Site(s):
Corpus Uteri
National Institutes of Health - ClinicalTrials.gov NCT Number: NCT04269200